OpenAI is preparing to launch a new artificial intelligence model that it said is capable of more advanced human-like ...

Novo Nordisk A/S’s failure to meet its own bar for success on a next-generation obesity shot shows the danger of promising ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Texas Instruments Inc. signed a final agreement for $1.6 billion in government grants to support construction of new ...

Hello and welcome to the newsletter, a grab bag of daily content from the Odd Lots universe. Sometimes it's us, Joe ...

Las acciones de la farmaceútuca danesa Novo Nordisk A/S registraron la mayor caída de su historia tras informar resultados ...

The office of South African President Cyril Ramaphosa said it welcomes the decision of the Energy Council of South Africa to ...

At first glance, Sony Group Corp.’s $1.2 billion acquisition of the anime streaming site Crunchyroll in 2021 looks like a ...

Volkswagen AG and labor leaders reached an agreement to cut capacity at its namesake brand while avoiding factory closures, ...

US short seller Gotham City Research asked a judge in New York to dismiss a lawsuit accusing it of conspiring to drive down ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Wilde, a Bloomberg UK journalist and editor on the Readout. We will be taking a break next week for Christmas, before ...